NMC Health plc
NMMCF · OTC
6/30/2019 | 12/31/2018 | 6/30/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.69 | 0.00 |
| FCF Yield | 0.00% | 1.49% | 1.06% | 1.03% |
| EV / EBITDA | 0.00 | 39.04 | 51.89 | 68.91 |
| Quality | ||||
| ROIC | 0.00% | 5.31% | 5.70% | 5.10% |
| Gross Margin | 0.00% | 40.89% | 40.89% | 39.63% |
| Cash Conversion Ratio | 1.51 | 1.51 | 1.32 | 1.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 45.24% | 42.61% | 39.47% | 35.62% |
| Free Cash Flow Growth | 0.00% | 0.00% | 4.79% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 7.13 | 7.09 | 7.16 |
| Interest Coverage | 0.00 | 3.39 | 3.39 | 5.15 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 2.46 | 2.91 | 2.67 |
| Cash Conversion Cycle | 0.00 | 61.42 | 52.36 | 65.36 |